CRL Q3 2020 Earnings Report — Charles River Laboratories International, Inc. Revenue & Financial Results | Market Cap Arena

Charles River Laboratories International, Inc.CRL

Q3 2020 Earnings

Reported November 9, 2020

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q3 2020	Q2 2020	Q3 2019	QoQ Change	YoY Change
Revenue	$743M	$683M	—	8.9%	—
Op. Income	$133M	$77M	—	72.9%	—
Gross Margin	38.9%	34.0%	—	4.9pp	—
Net Margin	13.8%	9.9%	—	4.0pp	—
EPS (Diluted)	$2.03	$1.34	—	51.5%	—
Free Cash Flow	$151M	$136M	—	11.5%	—

Revenue Flow

Item	Amount
REVENUE	$743M
Cost of Revenue	$454M
GROSS PROFIT	$289M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$128M
Other Expenses	$28M
Operating Expenses	$157M
Cost & Expenses	$611M
OPERATING INCOME	$133M
Interest Income	$179.0K
Interest Expense	$19M
Other Income/Expenses	$3M
INCOME BEFORE TAX	$135M
Income Tax Expense	$33M
Net Income from Continuing Ops	$103M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$103M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$103M
D&A	$60M
EBIT	$154M
EBITDA	$214M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$743M
Cost of Revenue	$454M
GROSS PROFIT	$289M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$128M
Other Expenses	$28M
Operating Expenses	$157M
Cost & Expenses	$611M
OPERATING INCOME	$133M
Interest Income	$179.0K
Interest Expense	$19M
Other Income/Expenses	$3M
INCOME BEFORE TAX	$135M
Income Tax Expense	$33M
Net Income from Continuing Ops	$103M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$103M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$103M
D&A	$60M
EBIT	$154M
EBITDA	$214M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$103M
Depreciation & Amortization	$60M
Stock-Based Compensation	$17M
Deferred Income Tax	-$3M
Other Non-Cash Items	-$14M
Change in Working Capital	$15M
OPERATING CASH FLOW	$177M
Capital Expenditure	-$26M
Acquisitions (Net)	-$37M
Purchases of Investments	-$8M
Sales/Maturities of Investments	$129.0K
Other Investing Activities	-$35.0K
NET CASH FROM INVESTING	-$71M
Net Debt Issuance	-$276M
Common Stock Repurchased	-$112.0K
Common Dividends Paid	$0
Other Financing Activities	$7M
NET CASH FROM FINANCING	-$269M
FREE CASH FLOW	$151M
Net Change in Cash	-$157M

Balance Sheet

Item	Amount
Cash & Equivalents	$243M
Short-Term Investments	$963.0K
Net Receivables	$572M
Inventory	$181M
Other Current Assets	$3M
TOTAL CURRENT ASSETS	$1.1B
PP&E (Net)	$1.2B
Goodwill	$1.8B
Intangible Assets	$803M
Long-Term Investments	$164M
Tax Assets	$40M
Other Non-Current Assets	$84M
TOTAL NON-CURRENT ASSETS	$4.1B
TOTAL ASSETS	$5.2B
Account Payables	$97M
Short-Term Debt	$45M
Deferred Revenue	$215M
Other Current Liabilities	$214M
TOTAL CURRENT LIABILITIES	$787M
Long-Term Debt	$1.9B
Deferred Revenue NC	$19M
Deferred Tax Liabilities	$202M
Other Non-Current Liabilities	$165M
TOTAL NON-CURRENT LIABILITIES	$2.5B
TOTAL LIABILITIES	$3.3B
Common Stock	$499.0K
Additional Paid-In Capital	$1.6B
Retained Earnings	$501M
Treasury Stock	-$24M
Accum. Other Comp. Income	-$195M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.9B
Minority Interest	$29M
TOTAL EQUITY	$1.9B
TOTAL LIABILITIES & EQUITY	$5.2B
Total Debt	$2.2B
Net Debt	$1.9B